Ledger.Open graph →
SEC Form D · filed June 9, 2020

Outlook Therapeutics, Inc

Offering
$16.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MONMOUTH JUNCTION, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Gerd G. Auffarth · Monmouth Junction, NJDirectorRandy Thurman · Monmouth Junction, NJDirectorJulian G. Gangolli · Monmouth Junction, NJDirectorYezan Haddadin · Monmouth Junction, NJDirectorKurt J. Hilzinger · Monmouth Junction, NJDirectorFaisal G. Sukhtian · Monmouth Junction, NJDirectorLawrence A. Kenyon · Monmouth Junction, NJExec · DirectorJeff G. Evanson · Cranbury, NJExecMichael S. Cunningham, M.D · Columbus, OHDirectorEric S. Espinosa, M.D · Columbus, OHDirectorBlake J. Nelson · Fargo, NDExec · DirectorChristi M. Offutt · Fargo, NDDirectorJon K. Aarsvold · Fargo, NDDirectorGhentry Pace · Columbus, OHDirectorGary M. Inman · Fargo, NDDirectorTerry G. Dagnon · Cranbury, NJExecCharles R. Kenley · WEST LAFAYETTE, INDirectorJoe F. Teague, Jr · Charlottes, NCDirectorWai S. Wong · Singapore, U0DirectorWilliam L. Lancaster · Calgary, British Columbia, CanadaExec · DirectorWendy B. Modlin · New York, NYDirectorAryeh B. Bourkoff · New York, NYDirectorEhren B. Stenzler · New York, NYDirectorJeff G. Evanson · Cranbury, NJExecTerry G. Dagnon · Cranbury, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗